SUHAIL COLON: Open Payments
NPI 1154952810 · KISSIMMEE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,415 in 45 payments from 13 companies in 2025. Trend: 2023 $985 · 2024 $1,277 · 2025 $1,415
Food & beverage: $1,316Education: $99
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 9 | $259 |
| ABBVIE INC. | 14 | $248 |
| Phathom Pharmaceuticals, Inc. | 2 | $243 |
| AstraZeneca Pharmaceuticals LP | 2 | $220 |
| Madrigal Pharmaceuticals | 7 | $138 |
| Amgen Inc. | 1 | $117 |
| Celltrion USA Inc. | 3 | $58 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $37 |
| Ipsen Biopharmaceuticals, Inc | 1 | $26 |
| GENZYME CORPORATION | 1 | $18 |
Products named: TREMFYA, VOQUEZNA, REZDIFFRA, CREON, AIRSUPRA, REPATHA, BREZTRI, SKYRIZI.
Industry payments across FL — which companies pay providers there.
